Aminocaproic Acid Injection, Solution
NDC Package 71872-7359-1
Package Information
Aminocaproic Acid injection is a medication used to help control bleeding due to a condition where your blood does not clot the way it normally should (fibrinolysis). This formulation utilizes a injection, solution delivery system. Marketed by Medical Purchasing Solutions, Llc, this product is identified by NDC 71872-7359 and is authorized under FDA application ANDA070010.
Identification & Billing
- RxCUI: 1718760 - aminocaproic acid 5 GM in 20 ML Injection
- RxCUI: 1718760 - 20 ML 6-aminocaproic acid 250 MG/ML Injection
- RxCUI: 1718760 - aminocaproic acid 5 GM per 20 ML Injection
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 71872 - Medical Purchasing Solutions, Llc
- 71872-7359 - Aminocaproic Acid
- 71872-7359-1 - 1 VIAL, SINGLE-DOSE in 1 BAG / 20 mL in 1 VIAL, SINGLE-DOSE
- 71872-7359 - Aminocaproic Acid
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 71872-7359-1 identifies a specific commercial package of 1 vial, single-dose in 1 bag / 20 ml in 1 vial, single-dose of Aminocaproic Acid, a human prescription drug labeled by Medical Purchasing Solutions, Llc. This injection, solution is formulated for intravenous use and contains aminocaproic acid as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Medical Purchasing Solutions, Llc on May 12, 2010. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used to help control bleeding due to a condition where your blood does not clot the way it normally should (fibrinolysis). This may cause serious bleeding after certain surgeries or in certain conditions (such as bleeding disorders, liver disease, cancer). Aminocaproic acid works by helping your blood clot normally. It belongs to a class of drugs known as antifibrinolytics.
How is this Medical Purchasing Solutions, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 71872735901. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.